Intrathecal Hydromorphone Combined with Transversalis Fascia Plane Block versus Patient-Conmintravenous Analgesia After Caesarean Delivery: A Randomised Controlled Trial
In brief
Hydromorphone and fascia block cut rescue analgesia after cesarean from 38% to 10%
In an 80-woman randomized trial, the combined regimen lowered rescue analgesia use from 37.5% with intravenous patient-controlled sufentanil to 10%, while pain scores were 0.6 to 0.9 points lower over 48 hours. It also shortened time to walking and lactation initiation by about five to six hours, but nausea and itching did not differ significantly. A small trial leaves the regimen's wider safety and effectiveness uncertain.
- Journal
- Journal of pain research (Q1)
- Published
- 9 November 2026
- Study design
- Randomized controlled trial
- Evidence level
- Level 1, High (CEBM 1b)
- Authors
- Kegong Wang, Lan Wang, Ting Gong, Haijin Wang
- PMID
- 43032653
- DOI
- 10.2147/JPR.S651135
Why clinicians should know about it
- Picked for Anesthesiology and Pain Medicine (paper of the day, 16 November 2026): Randomized multimodal analgesia trial after caesarean delivery
Abstract
BACKGROUND: Suboptimal analgesia after caesarean delivery delays recovery. Intrathecal hydromorphone and the transversalis fascia plane (TFP) block have each been proposed within multimodal analgesia, but a composite regimen omitting routine patient-controlled analgesia (PCIA) has not been compared with conventional intravenous PCIA. METHODS: Eighty women undergoing elective lower uterine segment caesarean delivery under spinal anaesthesia (March 2025 to September 2025) were randomly assigned 1:1 to intrathecal ropivacaine 10 mg with hydromorphone 50 µg, bilateral transversalis fascia plane (TFP) block (0.375% ropivacaine 20 mL per side) and no routine PCIA (n=40), or to intrathecal ropivacaine 10 mg alone followed by PCIA with sufentanil 1 µg/mL (n=40). The registered primary outcome analysed here was pain at rest and with activity over 48 h, tested with group × time repeated-measures analysis of variance. Secondary outcomes were protocol-defined rescue analgesia, adverse reactions, time to first ambulation, lactation initiation and satisfaction. RESULTS: Baseline characteristics were comparable (all standardised differences ≤0.18). The group × time interaction was significant for pain at rest (P=0.013) and with activity (P=0.019), and pain scores were lower in the hydromorphone-TFP arm at all five time points (mean difference 0.6-0.9 points; all P<0.001). Protocol-defined rescue analgesia was required by 10.0% versus 37.5% (risk ratio 0.27, 95% CI 0.10-0.73; P=0.004). Nausea/vomiting (12.5% vs 27.5%; P=0.094) and pruritus (7.5% vs 20.0%; P=0.105) did not differ, and no respiratory depression occurred. Ambulation (-5.3 h, 95% CI -7.0 to -3.6), lactation (-5.7 h, 95% CI -7.8 to -3.6) and satisfaction (+1.7 points, 95% CI 1.3-2.1) also favoured the hydromorphone-TFP arm (P<0.001). CONCLUSION: A composite regimen of intrathecal hydromorphone and bilateral TFP block without routine PCIA reduced pain scores and rescue analgesia requirements and shortened time to recovery milestones compared with sufentanil PCIA.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.